VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) traded down 11.8% during mid-day trading on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. 222,895 shares traded hands during mid-day trading, a decline of 24% from the average session volume of 293,391 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Down 9.1 %
The company has a market capitalization of C$24.33 million, a PE ratio of -4.63 and a beta of 0.39. The company’s 50 day moving average is C$0.11 and its two-hundred day moving average is C$0.13. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- What Does a Stock Split Mean?
- 3 Undervalued Stocks You Can Buy at a Discount Now
- What is the Shanghai Stock Exchange Composite Index?
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How to Short Nasdaq: An Easy-to-Follow Guide
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
